End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.8 CAD | +0.66% | -1.20% | -6.38% |
02:36am | J&J must pay $260 million in latest talc trial, Oregon jury says | RE |
03/06 | Legend Biotech Says Phase 2 Trial of Carvykti to Treat Multiple Myeloma Showed 'Deep, Durable' Responses | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- JNJ Stock
- JNJ Stock
- Charts Johnson & Johnson